The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II trial of high-dose methotrexate (HDMTX) followed by prophylactic glucarpidase in patients with impaired renal function and central nervous system lymphoma (CNSL).
 
Sven Liebig
Speakers' Bureau - Abbvie; SERB Pharmaceuticals
 
Peggy Kießling
No Relationships to Disclose
 
Sebastian Nagel
Stock and Other Ownership Interests - 3M; Ecolab Inc; GE Healthcare; Procter & Gamble; Solventum; Viracta Therapeutics
Consulting or Advisory Role - Siemens
 
Susen Burock
No Relationships to Disclose
 
Björn Chapuy
Honoraria - Abbvie; AstraZeneca/UK; Bristol-Myers Squibb; Gilead Sciences; Incyte; Johnson & Johnson; Roche; SOBI
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Gilead Sciences; Johnson & Johnson; Roche; SOBI
Research Funding - Roche
Patents, Royalties, Other Intellectual Property - Patens on molecular classification of DLBCL
Travel, Accommodations, Expenses - Roche; SOBI
 
Kai Kappert
No Relationships to Disclose
 
Ulrich Keller
Travel, Accommodations, Expenses - Abbvie; Janssen-Cilag; Lilly
 
Stefan Schwartz
Consulting or Advisory Role - Amgen; Pfizer; SERB Pharmaceuticals
Speakers' Bureau - Akademie für Infektionsmedizin e.V.; Amgen; CSi Hamburg GmbH; Pfizer; SERB Pharmaceuticals
Research Funding - Protherics Medicines Development Ltd
Travel, Accommodations, Expenses - Amgen; Pfizer; SERB Pharmaceuticals